Home / Stocks / Ajooni Biotech Limited
AJOONI

Ajooni Biotech Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹3.02

Change

+0.03 (1.0%)

Open

₹2.99

Prev. Close

₹2.99

Day High

₹3.08

Day Low

₹2.9

Volume Analysis

Traded

257,195

Delivered

87,492

Delivery %

34.02%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Promoter holding is rising

Weaknesses (1)

  • •Low operating margin (3.4%)

Opportunities (2)

  • •Strong 3-year EPS growth (31.5%)
  • •Strong 3-year revenue growth (35.0%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹3.28 ₹3.18 ₹3.1 ₹3.0 ₹2.92 ₹2.82 ₹2.74
Fibonacci ₹3.18 ₹3.11 ₹3.07 ₹3.0 ₹2.93 ₹2.89 ₹2.82
Camarilla ₹3.07 ₹3.05 ₹3.04 ₹3.0 ₹3.0 ₹2.99 ₹2.97

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-30.25%

1 Week

+5.23%

1 Month

+5.23%

3 Months

-18.82%

6 Months

-26.88%

1 Year

-37.47%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

4.25%

Net margin 2.2% × asset turnover 1.38x × equity multiplier 1.4x

Company Overview

Sector

Fast Moving Consumer Goods

Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.

TopFund Analysis

Ajooni Biotech Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 55/100. The strongest factor is Growth (100/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising; low operating margin (3.4%). Strong 3-year EPS growth (31.5%).

TopFund Score — Fundamentals Quality

55/100 — Average

Data confidence: 71/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

97

Growth

100

Cash Flow

0

Corporate Governance

51

Institutional Ownership

30

Business Quality

41

Risk & Volatility

40

Liquidity

50

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Updates 19 Oct

Ajooni Biotech confirms its website is updated and functional under SEBI Reg. 46.

Updates 15 Oct

Submitted Regulation 74(5) confirmation certificate for quarter ended 30 September 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 (S) Dec 2023 (S) Mar 2024 (S) Jun 2024 (S) Sep 2024 (S) Dec 2024 (S) Mar 2025 (S) Jun 2025 (S) Sep 2025 (S) Dec 2025 (S) Mar 2026 (S) Jun 2026 (S) Sep 2026 (S)
Sales + 19 20 20 26 26 34 29 31 32 59 61 63 65
Expenses + 19 21 18 25 25 33 28 31 30 56 60 62 63
Operating Profit 1 -1 2 1 1 1 1 1 2 3 1 2 2
OPM % 3.23% -3.24% 8.12% 3.74% 2.99% 2.73% 3.45% 2.27% 4.73% 5.16% 1.67% 2.63% 3.09%
Other Income + 0 2 0 0 0 0 1 1 0 0 1 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 1
Depreciation 0 0 0 0 0 0 0 0 0 1 1 1 1
Profit before tax 1 1 2 1 1 1 2 1 1 2 1 1 1
Tax % 23.08% 23.73% 38.67% 25.4% 22.78% 27.72% 19.37% 24.27% 24.39% 30.08% 15.18% 34.85% 28.17%
Net Profit + 0 0 1 0 1 1 2 1 1 2 1 0 1
EPS in Rs 0 0 0 0 0 0 0 0 0 0 0 0 0
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 89 89 -53 22 32 70 49 22 23 73 107 103 106

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Sales + 7 13 29 42 40 40 51 74 74 80 115 182
Expenses + 7 13 28 41 39 39 49 71 72 78 111 175
Operating Profit 0 0 1 1 1 1 2 3 3 2 4 6
OPM % 1.8% 1.7% 2.4% 2.2% 1.7% 3.1% 3.2% 4.2% 3.7% 2.8% 3.2% 3.4%
Other Income + 0 0 0 0 0 0 0 0 0 2 2 2
Interest 0 0 0 0 0 0 1 1 0 1 0 1
Depreciation 0 0 0 0 0 0 1 1 1 1 1 2
Profit before tax 0 0 0 0 0 0 0 1 2 3 4 6
Tax % 27.0% 29.0% 28.0% 20.0% 15.0% 29.0% 26.0% 28.0% 28.0% 28.0% 22.0% 25.0%
Net Profit + 0 0 0 0 0 0 0 1 1 2 3 4
EPS in Rs 0 0 0 0 0 0 0 0 0 0 0 0
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sales growth 1,165 84 116 48 -6 1 27 46 1 7 43 59

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S) Sep 2026 (S)
Reserves 0 0 1 5 6 7 6 6 24 25 54 57 58
Borrowings + 0 1 1 5 5 5 7 5 5 2 2 18 33
Other Liabilities + 1 1 11 4 1 2 6 7 12 3 5 11 6
Total Liabilities 2 2 13 19 18 23 28 29 59 48 95 120 132
Fixed Assets + 0 0 1 1 1 2 5 6 6 10 11 26 33
CWIP 0 0 0 0 0 0 0 0 0 1 0 0 0
Investments 0 0 6 6 4 3 1 1 4 2 3 2 3
Other Assets + 1 2 6 12 13 18 22 22 48 34 80 92 97
Total Assets 2 2 13 19 18 23 28 29 59 48 95 120 132
Equity Capital 0 0 0 6 6 8 10 10 18 18 34 34 36

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Cash from Operating Activity + 0 -1 -3 -3 -5 -4 1 4 -6 23 -32 -6
Cash from Investing Activity + 0 0 -2 0 1 0 -3 -2 -16 8 14 -16
Cash from Financing Activity + 0 1 5 8 -1 3 2 -2 22 -4 25 15
Net Cash Flow 0 0 0 5 -5 -1 0 0 0 27 6 -6
Free Cash Flow 0 -1 -3 -3 -5 -6 -2 2 -8 17 -33 -23
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 169 -257 -427 -284 -706 -353 71 125 -185 1,047 -845 -92

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 26.44% → 30.53%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 73.56% 73.56% 73.11% 72.82% 72.92% 73.11% 73.11% 73.11% 73.11% 73.11% 73.11% 69.47%
Promoters 26.44% 26.44% 26.89% 26.89% 26.89% 26.89% 26.89% 26.89% 26.89% 26.89% 26.89% 30.53%
FII 0.0% 0.0% 0.0% 0.29% 0.18% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Fast Moving Consumer Goods — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Ajooni Biotech Limited (this stock) — — — —
Hindustan Unilever Ltd. 471,951 42.1 9.66 31.0%
ITC Ltd 367,561 19.5 5.14 29.3%
Nestle India Limited 250,478 63.0 43.3 74.2%
Varun Beverages Limited 146,394 42.3 7.48 16.4%
Marico Limited 117,805 58.4 24.89 42.9%
Britannia Industries Ltd 113,545 42.5 26.78 53.5%

Which Mutual Funds Hold Ajooni Biotech Limited?

Frequently Asked Questions about Ajooni Biotech Limited

Community Sentiment

What are other investors saying about Ajooni Biotech Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.